299 related articles for article (PubMed ID: 15128729)
1. Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.
Koeth LM; Good CE; Appelbaum PC; Goldstein EJ; Rodloff AC; Claros M; Dubreuil LJ
J Antimicrob Chemother; 2004 Jun; 53(6):1039-44. PubMed ID: 15128729
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of 800 anaerobic isolates from patients with dentoalveolar infection to 13 oral antibiotics.
Kuriyama T; Williams DW; Yanagisawa M; Iwahara K; Shimizu C; Nakagawa K; Yamamoto E; Karasawa T
Oral Microbiol Immunol; 2007 Aug; 22(4):285-8. PubMed ID: 17600542
[TBL] [Abstract][Full Text] [Related]
3. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007.
Jamal W; Shahin M; Rotimi VO
Anaerobe; 2010 Feb; 16(1):1-5. PubMed ID: 19406247
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
Shore KP; Pottumarthy S; Morris AJ
N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
Koeth LM; Jacobs MR; Good CE; Bajaksouzian S; Windau A; Jakielaszek C; Saunders KA
Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
Henderson G; Garner J; Morris A
N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
[TBL] [Abstract][Full Text] [Related]
8. Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece.
Papaparaskevas J; Pantazatou A; Katsandri A; Legakis NJ; Avlamis A;
Clin Microbiol Infect; 2005 Oct; 11(10):820-4. PubMed ID: 16153256
[TBL] [Abstract][Full Text] [Related]
9. Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria.
Wybo I; Piérard D; Verschraegen I; Reynders M; Vandoorslaer K; Claeys G; Delmée M; Glupczynski Y; Gordts B; Ieven M; Melin P; Struelens M; Verhaegen J; Lauwers S
J Antimicrob Chemother; 2007 Jan; 59(1):132-9. PubMed ID: 17095529
[TBL] [Abstract][Full Text] [Related]
10. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
Jang SS; Breher JE; Dabaco LA; Hirsh DC
J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
Citron DM; Appleman MD
Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis.
Handal T; Olsen I; Walker CB; Caugant DA
Oral Microbiol Immunol; 2004 Oct; 19(5):303-8. PubMed ID: 15327642
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain.
van Winkelhoff AJ; Herrera D; Oteo A; Sanz M
J Clin Periodontol; 2005 Aug; 32(8):893-8. PubMed ID: 15998275
[TBL] [Abstract][Full Text] [Related]
14. Odontogenic bacteria in periodontal disease and resistance patterns to common antibiotics used as treatment and prophylaxis in odontology in Spain.
Maestre JR; Bascones A; Sánchez P; Matesanz P; Aguilar L; Giménez MJ; Pérez-Balcabao I; Granizo JJ; Prieto J
Rev Esp Quimioter; 2007 Mar; 20(1):61-7. PubMed ID: 17530037
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility variation of 50 anaerobic periopathogens in aggressive periodontitis: an interindividual variability study.
Lakhssassi N; Elhajoui N; Lodter JP; Pineill JL; Sixou M
Oral Microbiol Immunol; 2005 Aug; 20(4):244-52. PubMed ID: 15943770
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic sensitivity of anaerobic bacteria isolated during one year (1993)].
Durán MT; Molina F
Enferm Infecc Microbiol Clin; 1996; 14(6):370-6. PubMed ID: 8756216
[TBL] [Abstract][Full Text] [Related]
18. European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.
Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE;
Int J Antimicrob Agents; 2008 Apr; 31(4):316-20. PubMed ID: 18180149
[TBL] [Abstract][Full Text] [Related]
19. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
20. Comparative antianaerobic activity of BMS 284756.
Hoellman DB; Kelly LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2001 Feb; 45(2):589-92. PubMed ID: 11158759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
